CommercialCoverageMedium impact
Non-Invasive Surface Electrical Stimulation for Pain and Rehabilitation 1.01.61
Excellus BlueCross BlueShield·PM&R (Physical Medicine & Rehab), Pain Management, Physical Therapy +2 more·Durable Medical Equipment & Supplies
Effective date
May 21, 2026
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield updated their policy on electrical stimulation devices, establishing specific coverage criteria for TENS devices (requires 3+ months of pain, failed PT/medications, and 30-day trial), covering NMES only for disuse muscle atrophy, and excluding coverage for FES and several pain conditions including low back pain and neck pain.
Action Required
By May 21, 2026: Billing team must update prior authorization workflows for electrical stimulation devices to verify patients meet all coverage criteria including 3+ months of symptoms, failed conservative treatments, and documented 30-day trial efficacy. Update denial management processes for excluded conditions (low back pain, neck pain, headaches, TMJ, cancer pain). Train staff on new repair/replacement documentation requirements.